Arch Therapeutics
Established in 2006 and based out of Framingham, Massachusetts, Arch Therapeutics is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients.
Last updated on
About Arch Therapeutics
Estimated Revenue
$0-$1MEmployees
11-50Category
Location
City
FraminghamState
MassachusettsCountry
United StatesArch Therapeutics
Find your buyer within Arch Therapeutics